Cambodia vs Eritrea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Cambodia
0.4%
in 2024
Eritrea
0.5%
in 2024
Cambodia rank
59th
Eritrea rank
56th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Cambodia
- Eritrea
How they compare
Eritrea currently reports 0.5% against 0.4% in Cambodia, a difference of 0.1%.
That makes Eritrea's figure about 1.2 times Cambodia's.
Across all 10 years both countries report, Eritrea has been ahead every year.
Cambodia ranks 59th and Eritrea ranks 56th of 215 countries.
Eritrea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cambodia | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.6% | 0.2% | Eritrea |
| 2020s | 0.4% | 0.6% | 0.2% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Cambodia or Eritrea?
- Eritrea, at 0.5% against 0.4% in Cambodia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Cambodia and Eritrea?
- 0.1%, with Eritrea ahead.
- How many years of comparable data are there for Cambodia and Eritrea?
- 10 years are reported by both, from 2015 to 2024.
- How do Cambodia and Eritrea rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cambodia ranks 59th and Eritrea ranks 56th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.